Sanara Medtech Inc expected to post a loss of 11 cents a share - Earnings Preview
21/03/2025 13:02
Sanara Medtech Inc SMTI.OQ SMTI.O is expected to show a rise in quarterly revenue when it reports results on March 25 for the period ending December 31 2024 The Fort Worth Texas-based company is expected to report a 45.8% increase in revenue to $25.8 million from $17.69 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data. LSEG's mean analyst estimate for Sanara Medtech Inc is for a loss of 11 cents per share. The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Sanara Medtech Inc is $48.00, above its last closing price of $33.94. This summary was machine generated March 21 at 13:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)